We are an NCI-designated research center that moves laboratory discoveries into viable patient treatment options. Our research saves lives. We have been involved in the development of multiple cancer therapies now used worldwide. Our research scientists work with our clinical care physicians to develop cutting-edge therapies for our patients and their families. We train the next generation of cancer researchers through post-doctoral, graduate and college programs and high school mentorships.
With the growing and aging U.S. population, we must do a better job of preventing diseases like cancer and we simply have to do a better job of treating them when they do occur. We are fortunate that, across the U.S., we have an army of scientists and physicians who are poised to do the necessary research and, with the extraordinary advances in technology, the armaments for this war are available. In cancer, we also have a network of 68 National Cancer Institute-designated cancer centers, like the CTRC, that have a single focus: reducing the burden of cancer. We now must support that army.
Right now, several colleagues at The Cancer Therapy & Research Center are possibly on the cusp of one of the most important advances: The team found that the radioactive fat bubbles were taken up by brain cancers and result in remarkable rates of cure in animal models. Just over a year ago, the Food and Drug Administration granted the CTRC permission to initiate clinical trials with this agent. On March 10, 2015, the first patient was treated with this new technology, using highly sophisticated technology to precisely place a specially designed catheter into the brain tumor and infuse the nanoliposomes.
Researchers at the Cancer Therapy & Research Center at the UT Health Science Center were awarded more than $5 million in grants Wednesday that will help them in projects ranging from examining the on/off switch of a cancer-fighting molecule to preventing liver cancer in a majority Hispanic South Texas population.